Loading...
Daiichi Sankyo Company, Limited
DSKYF•PNK
Healthcare
Drug Manufacturers - General
$18.97
$-1.03(-5.15%)
U.S. Market opens in 8h 20mDaiichi Sankyo Company, Limited (DSKYF) AI-Powered Stock Analysis
See how Daiichi Sankyo Company, Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerDaiichi Sankyo Company, Limited (DSKYF) Stock Overall Grade
Daiichi Sankyo Company, Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Daiichi Sankyo Company, Limited's overall stock rating.
Forecast
BScore
63/100Financial Growth
AScore
80/100Fundamental Growth
AScore
80/100Key Ratios
B+Score
79/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100Daiichi Sankyo Company, Limited (DSKYF) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 63/100 (B), reflecting high confidence in its potential. Financial Growth (80/100, A) and Fundamental Growth (80/100, A) highlight its stability, while Key Ratios (79/100, B+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Daiichi Sankyo Company, Limited stock grade, including financials, comparisons, and forecasts.